An overview of the laboratory diagnosis of Pneumocystis jirovecii pneumonia
Journal of Clinical Microbiology · 12.03.2025 · 63 (3)
DOI: 10.1128/jcm.00361-24 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Microbiology, erschienen am 12.03.2025. Verfasst von Alexis Jaramillo Cartagena und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Microbiology Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Pneumonia, Pneumocystis, Pneumocystis carinii, Diagnostic Tests, Routine, Clinical Laboratory Techniques. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, HHS | NIH | National Cancer Institute.
Abstract (Originalsprache)
Pneumocystis jirovecii ( P. jirovecii ) is a fungal pathogen associated with significant morbidity in immunocompromised patients, including both HIV- and non-HIV-infected patients. The nonspecific clinical and radiological presentation makes clinical diagnostic challenging, emphasizing the need for accurate laboratory diagnostic tests. However, P. jirovecii does not grow in routine culture media, which presents diagnostic challenges in the laboratory as well. Recent publications from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium continue to rely on direct detection of P. jirovecii organisms in tissues and respiratory samples to define proven P. jirovecii pneumonia (PCP) even as the sensitivity of these methods are lower. Novel, standardized methods are needed to improve the clinical and laboratory diagnosis and management of PCP. This minireview provides an overview of current diagnostic tests for PCP and emerging applications that aim at filling existing diagnostic gaps and providing more accurate and less invasive diagnoses for this significant disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Microbiology Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Cytology Service, Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
- Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
ORCID-Profile: N Esther Babady
Förderung
- NCI NIH HHS
- HHS | NIH | National Cancer Institute
Zitieren
APA
Jaramillo Cartagena, A., Asowata, O. E., Ng, D., & Babady, N. E. (2025). An overview of the laboratory diagnosis of Pneumocystis jirovecii pneumonia. Journal of Clinical Microbiology, 63(3). https://doi.org/10.1128/jcm.00361-24
Vancouver
Jaramillo Cartagena A, Asowata OE, Ng D, Babady NE. An overview of the laboratory diagnosis of Pneumocystis jirovecii pneumonia. Journal of Clinical Microbiology. 2025;63(3). doi:10.1128/jcm.00361-24
BibTeX
@article{JaramilloCartagena2025,
author = {Jaramillo Cartagena, Alexis and Asowata, Osaretin Emmanuel and Ng, Dianna and Babady, N Esther},
title = {An overview of the laboratory diagnosis of Pneumocystis jirovecii pneumonia},
journal = {Journal of Clinical Microbiology},
year = {2025},
volume = {63},
number = {3},
doi = {10.1128/jcm.00361-24}
}
EUVIMED